Photorearrangement of dihetarylethenes as a tool for the benzannulation of heterocycles

文献信息

发布日期 2019-04-01
DOI 10.1039/C9OB00690G
影响因子 3.876
作者

Andrey G. Lvov, Vadim V. Kachala, Konstantin A. Lyssenko, Valerii Z. Shirinian


查看原文

摘要

A general strategy for the preparative benzannulation of aromatic heterocycles via photocyclization of 1,2-dihetarylethenes was proposed for the first time. The strategy includes two steps, namely, modular assembly of dihetarylethenes from widely available 3-hetarylacetic acids and 2-bromo-1-hetarylethanones, and subsequent preparative photorearrangement (using a UV lamp at 365 nm as the light source). This approach is efficient for the annulation of a wide range of heterocycles and provides C-, N-, O- or S-substituents in the benzoheterocycles obtained. The photochemical step is a metal-, acid-, and oxidant-free reaction, which requires non-inert conditions, and can be easily monitored by NMR spectroscopy. Applicability of the proposed strategy was tested in the synthesis of a wide range of substituted carbazoles and benzo[b]thiophenes as well as on a gram-scale benzannulation of 3-indoleacetic acid. Our study disclosed how to overcome two notable obstacles to the successful photorearrangement of dihetarylethenes: undesired reactions associated with photogenerated singlet oxygen, and the instability of desired products. The first problem was successfully solved by the addition of DABCO, while development of an in situ alkylation protocol to trap unstable photoproducts allowed us to overcome the second issue.

相关文献

Developing an efficient NiCo2S4 cocatalyst for improving the visible light H2 evolution performance of CdS nanoparticles

Junwen Peng, Junli Xu, Zhaoyu Wang, Zhengxin Ding, Sibo Wang

2017-09-11 Paper

DOI: 10.1039/C7CP05147F

Covalent-reaction-induced interfacial assembly to transform doxorubicin into nanophotomedicine with highly enhanced anticancer efficiency

Jinbo Fei, Ganglong Cui, Xiangyang Liu, Weihai Fang

2017-05-24 Paper

DOI: 10.1039/C7CP02543B

Probing the solvation structure and dynamics in ionic liquids by time-resolved infrared spectroscopy of 4-(dimethylamino)benzonitrile

Rômulo A. Ando, Samantha E. Brown-Xu, Lisa N. Q. Nguyen, Terry L. Gustafson

2017-09-04 Paper

DOI: 10.1039/C7CP04961G

Theoretical study on geometric, electronic and catalytic performances of Fe dopant pairs in graphene

Yanan Tang, Huadou Chai, Weiguang Chen, Xiao Cui, Yaqiang Ma, Mingyu Zhao

2017-09-08 Paper

DOI: 10.1039/C7CP05683D

Probe-location dependent resonance energy transfer at lipid/water interfaces: comparison between the gel- and fluid-phase of lipid bilayer

Moirangthem Kiran Singh, Mohammad Firoz Khan, Him Shweta, Sobhan Sen

2017-07-10 Paper

DOI: 10.1039/C7CP03108D

A lipophilic ionic liquid based on formamidinium cations and TFSI: the electric response and the effect of CO2 on the conductivity mechanism

Federico Bertasi, Guinevere A. Giffin, Keti Vezzù, Yaser Abu-Lebdeh, Michel Armand

2017-09-05 Paper

DOI: 10.1039/C7CP02304A

Catalytic mechanism of phenylacetone monooxygenases for non-native linear substrates

Miguel de Abreu, Lyndsey J. Ferguson, Derek J. Quinn, Thomas S. Moody, Meilan Huang

2017-09-07 Paper

DOI: 10.1039/C7CP03640J

Enhanced interfacial activity of multi-arm poly(ethylene oxide) star polymers relative to linear poly(ethylene oxide) at fluid interfaces

Yun-Ru Huang, Melissa Lamson, Krzysztof Matyjaszewski

2017-07-10 Paper

DOI: 10.1039/C7CP02841E

Structural relaxation, viscosity, and network connectivity in a hydrogen bonding liquid

Georg Ehlers, Joerg C. Neuefeind, Souleymane O. Diallo, Christopher B. Stanley, Luke Daemen

2017-07-21 Paper

DOI: 10.1039/C7CP04013J

您可能还喜欢

化合物问答

2-(甲基磺酰基)嘧啶-5-胺(CAS号:56621-92-2)适用哪些法规指南?

该化合物适用的法规指南包括GHS(全球化学品统一分类和标签制度)分类为特定目标器官毒性-单次接触类别3;根据欧盟REACH法规,该化合物需要进行注册和评估;在美...

56621-92-22-(Methylsulfonyl)py...
化合物问答

在合成中是否有4-(4-氯苯基)-1H-咪唑(CAS号:35512-29-9)的替代品?

在合成中,可以考虑使用一些类似的化合物作为4-(4-氯苯基)-1H-咪唑的替代品,如4-(4-溴苯基)-1H-咪唑或4-(4-甲氧基苯基)-1H-咪唑。这些化合...

35512-29-94-(4-Chlorophenyl)-1...
化合物问答

什么是N~2~-甲基丙氨酸酰胺(CAS号:32012-16-1)?

N~2~-甲基丙氨酸酰胺是一种有机化合物,其化学名为2-(Methylamino)propanamide。它是一种酰胺类化合物,分子式为C4H10N2O,相对分...

32012-16-12-(Methylamino)propa...
化合物问答

如何处理含有N-苄基-3-氨基氧杂环丁烷草酸盐(CAS号:1956341-96-0)的废料?

处理含有N-苄基-3-氨基氧杂环丁烷草酸盐(CAS号:1956341-96-0)的废料时,应首先确保遵循相关法规要求,如GHS和REACH等。通常,废液应先进行...

1956341-96-0N-Benzyloxetan-3-ami...
化合物问答

4-bromo-2-chloro-6-methylbenzoic acid(CAS号:877149-07-0)的物理化学性质是什么?

4-溴-2-氯-6-甲基苯甲酸是一种固体化合物,具有较高的熔点和较低的沸点。它的分子量为261.03 g/mol。该化合物在水中几乎不溶,在有机溶剂中溶解度适中...

877149-07-04-Bromo-2-chloro-6-m...
化合物问答

2-[(2,5-二氯-4-嘧啶)氨基]-N-甲基苯甲酰胺(CAS号:761440-08-8)通常如何合成?

该化合物通常通过缩合反应合成,典型的方法是将2,5-二氯嘧啶与N-甲基苯甲酰胺在碱性条件下进行偶联反应。常用的碱包括NaH、LDA等强碱。该合成路线具有较高的选...

761440-08-82-[(2,5-dichloropyri...
化合物问答

1,4-二氯肽嗪(CAS号:4752-10-7)安全吗?

1,4-二氯肽嗪属于有毒化学物质,需要在通风良好的实验条件下操作。应避免吸入其粉尘或蒸汽,接触皮肤或眼睛。

4752-10-71,4-Dichlorophthalaz...
化合物问答

在合成中是否有3,5-二溴-4-甲基苯胺(CAS号:13194-73-5)的替代品?

3,5-二溴-4-甲基苯胺在某些合成路线中可能没有直接替代品。然而,在某些应用场景下,可以考虑使用其他类似结构的化合物如3,5-二溴-4-硝基苯胺或3,5-二碘...

13194-73-53,5-Dibromo-4-methyl...
化合物问答

2-氯喹啉-4-羧酸甲酯(CAS号:62482-26-2)的主要用途是什么?

2-氯喹啉-4-羧酸甲酯主要用于有机合成和药物合成领域,作为中间体或原料。它在合成某些药物和染料时具有重要作用。此外,该化合物还可能用于某些特定的化学研究中。

62482-26-2Methyl 2-chloro-4-qu...
化合物问答

i>]吡啶(CAS号:474708-88-8)安全吗?

6-溴-8-氯咪唑[1,2-a]吡啶在操作过程中需要谨慎以确保安全。该化合物具有一定的毒性,吸入其蒸气或粉尘可能导致呼吸道刺激。处理时应佩戴适当的防护装备,如手...

474708-88-86-Bromo-8-chloroimid...

来源期刊

Organic & Biomolecular Chemistry

Organic & Biomolecular Chemistry
CiteScore: 3.4
自引率: 10.3%
年发文量: 1041

Organic & Biomolecular Chemistry (OBC) publishes original and high impact research and reviews in organic chemistry. We welcome research that shows new or significantly improved protocols or methodologies in total synthesis, synthetic methodology or physical and theoretical organic chemistry as well as research that shows a significant advance in the organic chemistry or molecular design aspects of chemical biology, catalysis, supramolecular and macromolecular chemistry, theoretical chemistry, mechanism-oriented physical organic chemistry, medicinal chemistry or natural products. Articles published in the journal should report new work which makes a highly-significant impact in the field. Routine and incremental work is generally not suitable for publication in the journal. More details about key areas of our scope are below. In all cases authors should include in their article clear rationale for why their research has been carried out.

推荐化合物

推荐供应商

免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 support@chemtradehub.com 联系我们。我们将及时核实并处理您的问题。